Lv1
40 积分 2024-08-10 加入
Tumor heterogeneity and cooperating cancer hallmarks driven by divergent EMT programs
6天前
已完结
TRIM29 facilitates gemcitabine resistance via MEK/ERK pathway and is modulated by circRPS29/miR-770–5p axis in PDAC
8天前
已完结
Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti–Programmed Cell Death‐1 in HCC
1个月前
已完结
Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression
1个月前
已完结
Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy
1个月前
已完结
皖公网安备34019202002308
